Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
Example Bundle: Alicia HIMSS IPS
id:
HIMSS-Alicia
Composition status:
final
Composition Type:
Patient summary Document
Subject:
identifier:
alicia-1-himss
Name:
Alicia HIMSS
active:
true
gender:
female
Birth Date:
1998-01-01
Sections
Allergies and Intolerances
Allergy:
Lactose (47703008)
clinicalStatus:
active
verificationStatus:
confirmed
Allergy:
Pollen (256259004)
clinicalStatus:
active
verificationStatus:
confirmed
Reaction:
Allergic rhinitis caused by pollen (21719001)
Problem List
Condition:
Gestational diabetes mellitus (disorder) (11687002)
clinicalStatus:
active
onsetDateTime:
2023
Condition:
Hypertensive disorder, systemic arterial (disorder) (38341003)
clinicalStatus:
active
asserter:
Dr. Walter Waltz
onsetDateTime:
2022
Medication Summary
Medication:
Irbesartan 75 mg Tablet
status:
active
Medication Detail:
-
System
https://spor.ema.europa.eu/pmswi
Code:
EU/1/97/049/001 [Karvea 75 mg Tablet]
-
System
https://www.who-umc.org/phpid
Code:
0x8DFB446EDB3B8AE508AE493827A704E4 [Irbesartan, 75 mg/ 1 tablet, Tablet]
-
System
http://www.whocc.no/atc
Code:
C09DA04 [irbesartan and diuretics]
Dose Form:
Tablet
Ingredient:
irbesartan (http://fdasis.nlm.nih.gov#J0E2756Z7N)
strength:
75 mg/1 Tablet
Route:
Oral use
Medication:
Metformin 500 mg Tablet
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-metformin [Metformin 500 mg tablets]
-
System
https://www.who-umc.org/phpid
Code:
himss1 [himss-1]
Dose Form:
Tablet
Ingredient:
metformin (http://fdasis.nlm.nih.gov#9100L32L2N)
strength:
500 mg/1 Tablet
Route:
Oral use
Medication:
Ibuprofen 600 mg Tablet
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-ibuprofen [Ibuprofen 600 mg Tablet]
-
System
https://www.who-umc.org/phpid
Code:
himss2 [himss-2]
Dose Form:
Tablet
Ingredient:
IBUPROFEN (http://fdasis.nlm.nih.gov#WK2XYI10QM)
strength:
600 mg/1 Tablet
Route:
Oral use
Relevant diagnostic tests &/or laboratory data
Observation:
Cholesterol [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
135 U/L (Abnormal) [30 U/L-110 U/L]
Observation:
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
55 mg/dL (Normal) [35 mg/dL-65 mg/dL]
Observation:
Cholesterol in LDL [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
110 mg/dL (Normal) [100 mg/dL-130 mg/dL]
Observation:
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-04-06T06:22:41-05:00
Result:
55 mg/dL (Normal) [35 mg/dL-65 mg/dL]
Observation:
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
55 mg/dL (Normal) [35 mg/dL-65 mg/dL]
Observation:
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
55.5 mg/dL (Normal) [35 mg/dL-65 mg/dL]
Observation:
Triglyceride [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
75 mg/dL (Normal) [0 mg/dL-150 mg/dL]
Observation:
Uric Acid
Status:
final
Issued:
2023-11-06T06:22:41-05:00
Result:
4.8 mg/dL (Normal) [2.7 mg/dL-7.3 mg/dL]
Observation:
Uric Acid
Status:
final
Issued:
2024-04-06T06:22:41-05:00
Result:
4.8 mg/dL (Normal) [2.7 mg/dL-7.3 mg/dL]
Observation:
Albumin [Mass/volume] in Serum or Plasma
Status:
final
Issued:
2024-05-05T06:22:41-05:00
Result:
4.7 g/dL (Normal) [3.4 g/dL-5.4 g/dL]
Document Reference:
Discharge summary
Status:
superseded
Date:
2024-04-06T06:22:41-05:00
Document Reference:
Discharge summary
Status:
superseded
Date:
2024-04-06T06:22:41-05:00
Document Reference:
Discharge summary
Status:
superseded
Date:
2024-04-06T06:22:41-05:00
Vital signs
Code:
Blood Pressure
Status:
final
Issued:
2024-04-06T06:22:41-05:00
Result:
Diastolic blood pressure || 60 mm[Hg]
Systolic blood pressure || 90 mm[Hg]
Code:
Heart Rate
Status:
final
Issued:
2024-04-06T06:22:41-05:00
Result:
108 bpm [60 bpm-100 bpm]
Code:
Blood Oxygen
Status:
final
Issued:
2024-04-06T06:22:41-05:00
Result:
96 % (Normal) [90 %-99 %]
Code:
Blood Pressure
Status:
final
Issued:
2024-04-07T06:22:41-05:00
Result:
Diastolic blood pressure || 90 mm[Hg]
Systolic blood pressure || 120 mm[Hg]
Code:
Heart Rate
Status:
final
Issued:
2024-04-07T06:22:41-05:00
Result:
80 bpm [60 bpm-100 bpm]
Code:
Blood Oxygen
Status:
final
Issued:
2024-04-07T06:22:41-05:00
Result:
99 % (Normal) [90 %-99 %]
Social history Narrative
Code:
Tobacco Smoking Status
status:
final
Result:
Age at starting smoking || 17
Age at smoking cessation || 35
Cigarette pack-years || 200
Pregnancy History
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
